secwatch.observer — SEC 8-K summary
======================================

Issuer:     GeoVax Labs, Inc. (GOVX)
CIK:        0000832489
Form:       8-K
Filed at:   2026-11-09T21:32:22+00:00
Accession:  0001437749-26-035911
Event type: leadership
Sentiment:  negative
Materiality: 0.75
Item codes: 5.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

GeoVax names Tyler O'Brien interim CEO and chairman; five directors resigned, Behroyan joins board
--------------------------------------------------------------------------------

- Tyler O'Brien appointed interim Chief Executive Officer effective Nov 8, 2026, also named Chairman of the Board, serving as principal executive officer until a permanent CEO is named.
- Shahin Behroyan, 39, appointed a director Nov 5, 2026; he has been CEO of iSpecimen (Nasdaq: ISPC) since Aug 26, 2026 and is deemed independent under Nasdaq Rule 5605(a)(2).
- Behroyan fills a board vacancy created by the resignation of five former directors effective Oct 23, 2026; he has no immediate committee assignment.
- Filing discloses Mr. Dodd's employment was terminated for 'Cause,' with potential severance of 3x base salary plus target bonus and accelerated stock option vesting if disputed.
- Company cites risks including Dodd litigation, going-concern doubt, and the need to regain and maintain Nasdaq continued listing compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/832489/000143774926035911/0001437749-26-035911-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/832489/000143774926035911/govx20261109_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-035911

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer